Literature DB >> 16515969

Outcome of renal tumors in young adults.

S Siemer1, M Hack, J Lehmann, F Becker, M Stöckle.   

Abstract

PURPOSE: Sporadic RCC is rare in young adults. We retrospectively reviewed the outcomes of patients 20 to 40 years old at our institution.
MATERIALS AND METHODS: Between 1975 and 2004, 2,710 patients were treated surgically for renal masses at our institution. We found 120 patients (4.4%) 20 to 40 years old. We analyzed the clinical presentation, pathological characteristics and outcome of these patients, and compared it to patients older than 40 years.
RESULTS: The mean age of 120 young adults was 34.1 years (range 20.4 to 39.8). Symptomatic presentation was documented in 49.5% of patients. RCC was found in 87 (72.5%) young adults. Young patients generally had a higher rate of organ confined tumors than patients older than 40 years (73.6% vs 59.3%, p <0.05). Histopathological characteristics, tumor size, lymph node metastases and distant metastatic disease did not differ significantly in young and older patients. Women were significantly more likely to have benign lesions (41% vs 20%, p <0.05). Mean followup for 120 patients was 80.6 months and 15 of 87 patients with RCC (17.2%) died of tumor related causes (mean followup 27.5 months). The 10-year cancer specific survival rate was 78% in young adults and 68% in older patients (p = 0.22). Multivariate Cox regression analysis revealed lymph node metastases and tumor differentiation grade as independent prognostic parameters in young patients.
CONCLUSIONS: Young patients are more likely to have symptomatic tumors at presentation. Nevertheless, they have more favorable pathological features and a definite trend to superior disease specific survival following surgical treatment. Organ sparing surgery should be considered in young women since benign lesions are frequent found in this population.

Entities:  

Mesh:

Year:  2006        PMID: 16515969     DOI: 10.1016/S0022-5347(05)00696-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014.

Authors:  Jae Heon Kim; Shufeng Li; Yash Khandwala; Kyung Jin Chung; Hyung Keun Park; Benjamin I Chung
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

2.  Renal cell carcinoma: Are we attacking a different tumor over the past 10 years?

Authors:  Ahmed Fouad Kotb; Doaa Attia; Mohamed Mohie Hashad; Tamer Mohammed Abou Youssif; Nora Abdelkawy; Asmaa Ismail; Ahmed Elabbady; Mohamed Adel Atta
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

3.  Partial and radical nephrectomy in children, adolescents, and young adults: Equivalent readmissions and postoperative complications.

Authors:  M Hassan Alkazemi; Zachary R Dionise; Ruiyang Jiang; Steven Wolf; Gina-Maria Pomann; Elisabeth T Tracy; Henry E Rice; Jonathan C Routh
Journal:  J Pediatr Surg       Date:  2019-05-31       Impact factor: 2.545

Review 4.  Gender differences in benign renal masses.

Authors:  Julian Mauermann; Michela de Martino; Matthias Waldert; Andrea Haitel; Hans Christoph Klingler; Mesut Remzi; Tobias Klatte
Journal:  World J Urol       Date:  2013-02-16       Impact factor: 4.226

5.  Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.

Authors:  Jeremiah J Morrissey; Jonathan Mobley; R Sherburne Figenshau; Joel Vetter; Sam Bhayani; Evan D Kharasch
Journal:  Mayo Clin Proc       Date:  2015-01       Impact factor: 7.616

6.  The relationship between histopathology and age factor in patients who were operated for renal masses.

Authors:  Taha Numan Yıkılmaz; Okan Baş; Ali İhsan Arık; Fatih Hızlı; Halil Başar
Journal:  Turk J Urol       Date:  2015-06

Review 7.  Renal Cancer in Recipients of Kidney Transplant.

Authors:  Prajwal Dhakal; Smith Giri; Krishmita Siwakoti; Supratik Rayamajhi; Vijaya Raj Bhatt
Journal:  Rare Tumors       Date:  2017-03-24

8.  Kaempferol Inhibits the Invasion and Migration of Renal Cancer Cells through the Downregulation of AKT and FAK Pathways.

Authors:  Tung-Wei Hung; Pei-Ni Chen; Hsu-Chen Wu; Sheng-Wen Wu; Pao-Yu Tsai; Yih-Shou Hsieh; Horng-Rong Chang
Journal:  Int J Med Sci       Date:  2017-08-18       Impact factor: 3.738

Review 9.  Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects.

Authors:  Kenneth G Liu; Sorab Gupta; Sanjay Goel
Journal:  Oncotarget       Date:  2017-03-07

10.  Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?

Authors:  Stefan Denzinger; Wolfgang Otto; Maximilian Burger; Christine Hammerschmied; Kerstin Junker; Arndt Hartmann; Wolf F Wieland; Bernhard Walter
Journal:  World J Surg Oncol       Date:  2007-02-05       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.